Different antiviral effects of IFNα and IFNβ in an HBV mouse model.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Immunobiology

• Publication date

  2017-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.imbio.2016.11.003PMID 27839836
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections

  2015cited by this paper
• Mouse Models of Hepatitis B Virus Pathogenesis.

  2015cited by this paper
• Interfering with Immunity: Detrimental Role of Type I IFNs during Infection

  2015cited by this paper
• Type I interferons in infectious disease

  2015cited by this paper
• Immune cell responses are not required to induce substantial hepatitis B virus antigen decline during pegylated interferon-alpha administration.

  2014cited by this paper
• Reduction of HBV replication prolongs the early immunological response to IFNα therapy.

  2014cited by this paper
• Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA

  2014cited by this paper
• Susceptibility of Different Hepatitis B Virus Isolates to Interferon-Alpha in a Mouse Model Based on Hydrodynamic Injection

  2014cited by this paper
• Infection: The interferon paradox

  2013cited by this paper
• Persistent LCMV Infection Is Controlled by Blockade of Type I Interferon Signaling

  2013cited by this paper
• Blockade of Chronic Type I Interferon Signaling to Control Persistent LCMV Infection

  2013cited by this paper
• Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B.

  2013cited by this paper
• Dissecting the divergent effects of interferon-alpha on immune cells: time to rethink combination therapy in chronic hepatitis B?

  2013cited by this paper
• Immunocompetent nontransgenic mouse models for studying hepatitis B virus immune responses

  2013cited by this paper
• Hepatitis B virus polymerase impairs interferon‐α–induced STA T activation through inhibition of importin‐α5 and protein kinase C‐δ

  2013cited by this paper
• The interferon paradox

  2013cited by this paper
• An Interferon Paradox

  2013cited by this paper
• Interferon-α suppresses hepatitis B virus enhancer II activity via the protein kinase C pathway.

  2012cited by this paper
• Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity.

  2012cited by this paper
• IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome.

  2012cited by this paper
• Systematic identification of type I and type II interferon-induced antiviral factors

  2012cited by this paper
• IFN-α enhances cross-presentation in human dendritic cells by modulating antigen survival, endocytic routing, and processing.

  2012cited by this paper
• Peginterferon-α does not improve early peripheral blood HBV-specific T-cell responses in HBeAg-negative chronic hepatitis.

  2012cited by this paper
• Hepatitis B virus limits response of human hepatocytes to interferon-α in chimeric mice.

  2011cited by this paper
• A diverse array of gene products are effectors of the type I interferon antiviral response

  2011cited by this paper
• Effects of Interferon-α/β on HBV Replication Determined by Viral Load

  2011cited by this paper
• Binding and activity of all human alpha interferon subtypes.

  2011cited by this paper
• Interferons Accelerate Decay of Replication-Competent Nucleocapsids of Hepatitis B Virus

  2010cited by this paper
• Type I interferon: friend or foe?

  2010cited by this paper
• Pathogenesis of hepatitis B virus infection.

  2010cited by this paper
• In vitro characterization of viral fitness of therapy-resistant hepatitis B variants.

  2009cited by this paper
• Temporal treatment with interferon-beta prevents hepatocellular carcinoma in hepatitis B virus X gene transgenic mice.

  2008cited by this paper
• Comparable potency of IFNα2 and IFNβ on immediate JAK/STAT activation but differential down-regulation of IFNAR2

  2007cited by this paper
• The receptor of the type I interferon family.

  2007cited by this paper
• Comparable potency of IFNalpha2 and IFNbeta on immediate JAK/STAT activation but differential down-regulation of IFNAR2.

  2007cited by this paper
• Toll‐like receptor‐mediated control of HBV replication by nonparenchymal liver cells in mice

  2007cited by this paper
• Differential receptor subunit affinities of type I interferons govern differential signal activation.

  2007cited by this paper
• An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection

  2006cited by this paper
• Inhibition of Alpha Interferon Signaling by Hepatitis B Virus

  2006cited by this paper
• Variations in the unstructured C-terminal tail of interferons contribute to differential receptor binding and biological activity.

  2006cited by this paper
• Interferon prevents formation of replication-competent hepatitis B virus RNA-containing nucleocapsids.

  2005cited by this paper
• Type I interferon differential therapy for erythroleukemia: specificity of STAT activation.

  2003cited by this paper
• Transcriptional and posttranscriptional control of hepatitis B virus gene expression

  2003cited by this paper
• Interferon-Regulated Pathways That Control Hepatitis B Virus Replication in Transgenic Mice

  2002cited by this paper
• Type I interferon gene therapy protects against cytomegalovirus‐induced myocarditis

  2002cited by this paper
• A pilot study of beta-interferon for treatment of patients with chronic hepatitis B who failed to respond to alpha-interferon.

  2002cited by this paper
• A pilot study of β-interferon for treatment of patients with chronic hepatitis B who failed to respond to α-interferon

  2002cited by this paper
• Noncytolytic control of viral infections by the innate and adaptive immune response.

  2001cited by this paper
• Relative Sensitivity of Hepatitis B Virus and Other Hepatotropic Viruses to the Antiviral Effects of Cytokines

  2000cited by this paper
• Intrahepatic Induction of Alpha/Beta Interferon Eliminates Viral RNA-Containing Capsids in Hepatitis B Virus Transgenic Mice

  2000cited by this paper
• Differential viral induction of distinct interferon‐α genes by positive feedback through interferon regulatory factor‐7

  1998cited by this paper
• Pilot interferon-beta trial in children with chronic hepatitis B who had previously not responded to interferon-alpha therapy.

  1997cited by this paper
• High-level hepatitis B virus replication in transgenic mice

  1995cited by this paper
• Hepatitis B virus immunopathogenesis.

  1995cited by this paper
• Alpha interferon suppresses hepatitis B virus enhancer activity and reduces viral gene transcription

  1990cited by this paper
• Interferon inhibits hepatitis B virus replication in a stable expression system of transfected viral DNA

  1989cited by this paper
• Hepatitis B virus (HBV) particles are produced in a cell culture system by transient expression of transfected HBV DNA.

  1987cited by this paper

• Interferon-induced polarization of M1 macrophages mediates antiviral activity against the hepatitis B virus via the hepcidin-ferroportin axis.

  2024cites this paper
• Farnesoid X Receptor Activation Decreases Toll-like Receptor 2 Expression by Upregulating HBeAg Production

  2023cites this paper
• Hepcidin expression levels involve efficacy of pegylated interferon-α treatment in hepatitis B-infected liver.

  2022cites this paper
• Simultaneous or Prior Activation of Intrahepatic Type I Interferon Signaling Leads to Hepatitis B Virus Persistence in a Mouse Model

  2021cites this paper
• Context Is Key: Delineating the Unique Functions of IFNα and IFNβ in Disease

  2020influential citation
• Controversial: Early Innate Responses to Hepatitis B Virus Infection, an Explanation for Viral Persistence?

  2020cites this paper
• Hepatitis B virus reactivation after successful treatment of hepatitis C virus with sofosbuvir and ribavirin

  2020cites this paper
• Induction of interleukin 6 impairs the anti‐HBV efficiency of IFN‐α in human hepatocytes through upregulation of SOCS3

  2019cites this paper
• The present situation and prospect of research on HBeAg-negative mouse model

  2019cites this paper
• Antiviral activity of minicircle DNA-mediated shRNA in HBV transgenic mice

  2017cites this paper
• Spontaneous remission of hepatitis B virus reactivation during direct‐acting antiviral agent‐based therapy for chronic hepatitis C

  2017cites this paper